New schizophrenia drug could treat Alzheimer's disease
A new era in psychiatric medicine is suggested by the approval of innovative drugs, though not all trials yield positive results.
Revolutionary drug for schizophrenia wins US approval
KarXT represents a groundbreaking schizophrenia treatment with a unique mechanism of action that may improve patient outcomes and tolerability compared to existing therapies.
For the first time in decades, we have a new kind of schizophrenia drug
Cobenfy is a groundbreaking drug that targets muscarinic receptors, potentially offering a new treatment avenue for schizophrenia sufferers.
New schizophrenia drug could treat Alzheimer's disease
A new era in psychiatric medicine is suggested by the approval of innovative drugs, though not all trials yield positive results.
Revolutionary drug for schizophrenia wins US approval
KarXT represents a groundbreaking schizophrenia treatment with a unique mechanism of action that may improve patient outcomes and tolerability compared to existing therapies.
For the first time in decades, we have a new kind of schizophrenia drug
Cobenfy is a groundbreaking drug that targets muscarinic receptors, potentially offering a new treatment avenue for schizophrenia sufferers.